Allstate Corp Makes New $800,000 Investment in Teradyne, Inc. $TER

Allstate Corp bought a new stake in shares of Teradyne, Inc. (NASDAQ:TERFree Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 5,812 shares of the company’s stock, valued at approximately $800,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Hemington Wealth Management lifted its position in Teradyne by 43.2% during the third quarter. Hemington Wealth Management now owns 262 shares of the company’s stock valued at $36,000 after purchasing an additional 79 shares during the last quarter. Versant Capital Management Inc lifted its holdings in shares of Teradyne by 5.8% in the 3rd quarter. Versant Capital Management Inc now owns 1,494 shares of the company’s stock valued at $206,000 after acquiring an additional 82 shares during the last quarter. LS Investment Advisors LLC grew its position in Teradyne by 2.3% in the third quarter. LS Investment Advisors LLC now owns 3,945 shares of the company’s stock worth $543,000 after acquiring an additional 89 shares in the last quarter. Manchester Capital Management LLC increased its stake in Teradyne by 29.4% during the second quarter. Manchester Capital Management LLC now owns 586 shares of the company’s stock worth $53,000 after acquiring an additional 133 shares during the last quarter. Finally, Outlook Wealth Advisors LLC raised its position in Teradyne by 4.8% during the second quarter. Outlook Wealth Advisors LLC now owns 3,452 shares of the company’s stock valued at $310,000 after purchasing an additional 157 shares during the period. 99.77% of the stock is owned by hedge funds and other institutional investors.

Teradyne Stock Performance

Shares of NASDAQ TER opened at $231.89 on Thursday. Teradyne, Inc. has a 52-week low of $65.77 and a 52-week high of $238.92. The firm has a market capitalization of $36.32 billion, a price-to-earnings ratio of 84.32, a PEG ratio of 1.61 and a beta of 1.84. The stock has a 50 day moving average price of $197.25 and a 200 day moving average price of $150.48.

Teradyne (NASDAQ:TERGet Free Report) last issued its earnings results on Wednesday, October 29th. The company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.07. Teradyne had a return on equity of 18.04% and a net margin of 15.49%.The business had revenue of $769.21 million during the quarter, compared to analyst estimates of $744.20 million. During the same period in the previous year, the company posted $0.90 EPS. Teradyne’s revenue was up 4.3% on a year-over-year basis. Analysts forecast that Teradyne, Inc. will post 3.88 earnings per share for the current year.

Teradyne Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, December 17th. Investors of record on Monday, November 24th were paid a $0.12 dividend. The ex-dividend date of this dividend was Monday, November 24th. This represents a $0.48 dividend on an annualized basis and a yield of 0.2%. Teradyne’s dividend payout ratio is 17.45%.

Insider Transactions at Teradyne

In other Teradyne news, CEO Gregory Stephen Smith sold 1,108 shares of the firm’s stock in a transaction dated Friday, December 12th. The shares were sold at an average price of $201.31, for a total transaction of $223,051.48. Following the transaction, the chief executive officer owned 93,409 shares of the company’s stock, valued at approximately $18,804,165.79. This trade represents a 1.17% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.16% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Cantor Fitzgerald reissued an “overweight” rating and set a $240.00 target price on shares of Teradyne in a research report on Tuesday, December 16th. The Goldman Sachs Group raised shares of Teradyne from a “sell” rating to a “buy” rating and lifted their price objective for the stock from $148.00 to $230.00 in a research note on Monday, December 15th. Stifel Nicolaus boosted their price objective on shares of Teradyne from $225.00 to $270.00 and gave the company a “buy” rating in a research report on Wednesday, January 14th. UBS Group increased their target price on shares of Teradyne from $165.00 to $200.00 and gave the company a “buy” rating in a research note on Thursday, October 30th. Finally, Morgan Stanley lifted their price target on shares of Teradyne from $100.00 to $136.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 14th. Eleven investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $200.44.

Read Our Latest Analysis on TER

Teradyne Profile

(Free Report)

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.

Recommended Stories

Want to see what other hedge funds are holding TER? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teradyne, Inc. (NASDAQ:TERFree Report).

Institutional Ownership by Quarter for Teradyne (NASDAQ:TER)

Receive News & Ratings for Teradyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teradyne and related companies with MarketBeat.com's FREE daily email newsletter.